ArticleBioengineered2024

Statement of Retraction: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.